Serveur d'exploration MERS - Corpus (Pmc)

Index « PmcKwd.i » - entrée « Treatment »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Traveller < Treatment < Treatment outcome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000058 (2015) Yong Pil Chong ; Joon Young Song ; Yu Bin Seo ; Jae-Phil Choi ; Hyoung-Shik ShinAntiviral Treatment Guidelines for Middle East Respiratory Syndrome
000202 (2020) Influenza, Measles, SARS, MERS, and Smallpox
000211 (2016) The Middle East Respiratory Syndrome Coronavirus – A Continuing Risk to Global Health Security
000660 (2019) Emmie De Wit ; Friederike Feldmann ; Eva Horne ; Atsushi Okumura ; Elisabetta Cameroni ; Elaine Haddock ; Greg Saturday ; Dana Scott ; Robin Gopal ; Maria Zambon ; Davide Corti ; Heinz FeldmannProphylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset
000A73 (2017) Neeltje Van Doremalen ; Darryl Falzarano ; Tianlei Ying ; Emmie De Wit ; Trenton Bushmaker ; Friederike Feldmann ; Atsushi Okumura ; Yanping Wang ; Dana P. Scott ; Patrick W. Hanley ; Heinz Feldmann ; Dimiter S. Dimitrov ; Vincent J. MunsterEfficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
000A77 (2016) Hongjie Qiu ; Shihui Sun ; He Xiao ; Jiannan Feng ; Yan Guo ; Wanbo Tai ; Yufei Wang ; Lanying Du ; Guangyu Zhao ; Yusen ZhouSingle-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
000D31 (2020) Shuntong Kang ; Wenyao Peng ; Yuhao Zhu ; Shiyao Lu ; Min Zhou ; Wei Lin ; Wenfang Wu ; Shu Huang ; Liping Jiang ; Xuan Luo ; Meichun DengRecent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
000E38 (2016) Jean-François RossignolNitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
001291 (2020) Mahmoud Yousefifard ; Alireza Zali ; Kosar Mohamed Ali ; Arian Madani Neishaboori ; Afshin Zarghi ; Mostafa Hosseini ; Saeed SafariAntiviral therapy in management of COVID-19: a systematic review on current evidence
001293 (2016) David S. HuiEpidemic and Emerging Coronaviruses (Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome)
001345 (2019) Esam I. Azhar ; David S. C. Hui ; Ziad A. Memish ; Christian Drosten ; Alimuddin ZumlaThe Middle East Respiratory Syndrome (MERS)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Pmc/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/PmcKwd.i -k "Treatment" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/PmcKwd.i  \
                -Sk "Treatment" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    indexItem
   |index=    PmcKwd.i
   |clé=    Treatment
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021